Cargando…

Management of metastatic melanoma in Texas: disparities in the utilization of immunotherapy following the regulatory approval of immune checkpoint inhibitors

BACKGROUND: The utilization of modern-immunotherapies, notably immune checkpoint inhibitors (ICIs), has increased markedly in patients with metastatic melanoma over the past decade and are recommended as standard treatment. Given their increasing adoption in routine care for melanoma, understanding...

Descripción completa

Detalles Bibliográficos
Autores principales:	Olateju, Olajumoke A., Zeng, Zhen, Thornton, J. Douglas, Mgbere, Osaro, Essien, Ekere James
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339559/ https://www.ncbi.nlm.nih.gov/pubmed/37442992 http://dx.doi.org/10.1186/s12885-023-11142-4

Ejemplares similares

Evaluation of the Sociodemographic, Behavioral and Clinical Influences on Complete Antiretroviral Therapy Adherence Among HIV-Infected Adults Receiving Medical Care in Houston, Texas
por: Sok, Pagna, et al.
Publicado: (2021)

Population-based assessment of the burden of COVID-19 infection in African countries: a first-year report card and public health implications
por: Mgbere, Osaro, et al.
Publicado: (2023)

Polypharmacy among COVID-19 patients: A systematic review
por: Iloanusi, Sorochi, et al.
Publicado: (2021)

Correlates of HIV knowledge and sexual risk behaviors among female military personnel
por: Essien, Ekere, et al.
Publicado: (2010)

COVID-19 Infection among People with HIV/AIDS in Africa: Knowledge Gaps, Public Health Preparedness and Research Priorities
por: Essien, Ekere James, et al.
Publicado: (2021)

Systemic Delays in the Initiation of Antiretroviral Therapy for Clinically Eligible HIV-Infected Patients in Houston, Texas: The Providers’ Report Card
por: Mgbere, Osaro, et al.
Publicado: (2018)

Assessment of sexually transmitted disease/HIV risk among young African Americans: comparison of self-perceived and epidemiological risks utilizing ecodevelopmental theory
por: Li, Ya-Huei, et al.
Publicado: (2019)

HIV Non-Occupational Post Exposure Prophylaxis in Nigeria: A Systematic Review of Research Evidence and Practice
por: Iloanusi, Sorochi H., et al.
Publicado: (2019)

Modeling ecodevelopmental context of sexually transmitted disease/HIV risk and protective behaviors among African-American adolescents
por: Li, Ya-Huei, et al.
Publicado: (2017)

Intersection of Perceived COVID-19 Risk, Preparedness, and Preventive Health Behaviors: Latent Class Segmentation Analysis
por: Mgbere, Osaro, et al.
Publicado: (2023)

Prevalence and risk factors of high cholesterol and triglycerides among people with HIV in Texas
por: Buendia, Justin, et al.
Publicado: (2022)

Impact of short-term antiretroviral therapy (START) on some fibrinolytic markers in HIV-infected Nigerian adults: preliminary findings from the START study
por: Jeremiah, Zaccheaus A, et al.
Publicado: (2012)

Elevation in D-dimer concentrations is positively correlated with gestation in normal uncomplicated pregnancy
por: Jeremiah, Zaccheaus A, et al.
Publicado: (2012)

Public opinion regarding government response to COVID-19: case study of a large commercial city in Nigeria
por: Yunusa, Ismaeel, et al.
Publicado: (2021)

Commercial Sex Work During Novel Coronavirus (SARS-CoV-2) Era in the Niger Delta Region: Relationships Between Knowledge, Preventive Practice, and Transmission Potential
por: Avwioro, Godwin, et al.
Publicado: (2021)

Demographic Determinants of Influenza Vaccination and Infection, Brazos County, Texas, 2017
por: Akpalu, Yao, et al.
Publicado: (2019)

Investigation of racial differences in survival from non-small cell lung cancer with immunotherapy use: A Texas study
por: Olateju, Olajumoke A., et al.
Publicado: (2023)

Clinical epidemiology of carbapenem-resistant Enterobacterales in the Greater Houston region of Texas: a 6-year trend and surveillance analysis
por: Tadese, Bekana K., et al.
Publicado: (2022)

Adherence to antiretroviral therapy in Nigeria: an overview of research studies and implications for policy and practice
por: Monjok, Emmanuel, et al.
Publicado: (2010)

Checkpoint Inhibitors Immunotherapy in Metastatic Melanoma: When to Stop Treatment?
por: De Risi, Ivana, et al.
Publicado: (2022)

Predictors of frequency of condom use and attitudes among sexually active female military personnel in Nigeria
por: Essien, E James, et al.
Publicado: (2010)

EPH189 Assessment of Burden of COVID-19 Infection and the Dynamics in African Union Member States
por: Mgbere, O., et al.
Publicado: (2023)

Cancer Immunotherapy Update: FDA-Approved Checkpoint Inhibitors and Companion Diagnostics
por: Twomey, Julianne D., et al.
Publicado: (2021)

Pediatric diarrhea patients living in urban areas have a higher incidence of Clostridioides difficile infection
por: Adesoji, Ayodele T., et al.
Publicado: (2023)

Are tumor size changes predictive of survival for checkpoint blockade based immunotherapy in metastatic melanoma?
por: Wang, Meihua, et al.
Publicado: (2019)

A population-based assessment of metastatic hepatoblastoma in Texas reveals ethnic disparities
por: Espinoza, Andres F., et al.
Publicado: (2023)

Comprehensive Clinical Trial Data Summation for BRAF‐MEK Inhibition and Checkpoint Immunotherapy in Metastatic Melanoma
por: Luke, Jason J.
Publicado: (2019)

Latest Approved Therapies for Metastatic Melanoma: What Comes Next?
por: Menaa, Farid
Publicado: (2013)

Modern Aspects of Immunotherapy with Checkpoint Inhibitors in Melanoma
por: Petrova, Vera, et al.
Publicado: (2020)

Evolution of preclinical characterization and insights into clinical pharmacology of checkpoint inhibitors approved for cancer immunotherapy
por: Kasichayanula, Sreeneeranj, et al.
Publicado: (2022)

No Impact of NRAS Mutation on Features of Primary and Metastatic Melanoma or on Outcomes of Checkpoint Inhibitor Immunotherapy: An Italian Melanoma Intergroup (IMI) Study
por: Guida, Michele, et al.
Publicado: (2021)

Immunotherapy for Melanoma: The Significance of Immune Checkpoint Inhibitors for the Treatment of Advanced Melanoma
por: Fujimura, Taku, et al.
Publicado: (2022)

Disparity in outcomes of melanoma adjuvant immunotherapy by demographic profile
por: Ikeguchi, Alexandra, et al.
Publicado: (2020)

Targeting regulatory T cells for immunotherapy in melanoma
por: Huang, Lili, et al.
Publicado: (2021)

Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanoma
por: Ho, Joel, et al.
Publicado: (2022)

Complications of sequential immunotherapy in metastatic melanoma
por: Bufalino, Shams, et al.
Publicado: (2015)

uPAR(+) extracellular vesicles: a robust biomarker of resistance to checkpoint inhibitor immunotherapy in metastatic melanoma patients
por: Porcelli, Letizia, et al.
Publicado: (2021)

PIN1 Polypharmacy Among COVID-19 Patients: A Prisma-Based Systematic Review of Available Literature
por: Iloanusi, S., et al.
Publicado: (2021)

Sex Disparities of Genomic Determinants in Response to Immune Checkpoint Inhibitors in Melanoma
por: Shi, Fuyan, et al.
Publicado: (2021)

Combination Strategies of Checkpoint Immunotherapy in Metastatic Breast Cancer
por: Liu, Zhi Bing, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hqf1jsb32qne5qv5sud8g52126